Join to View Full Profile
3901 Rainbow BlvdStop 3016Kansas City, KS 66160
Phone+1 913-588-6147
Fax+1 913-588-7625
Dr. Holzbeierlein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterResidency, Urology, 1996 - 2000
University of Tennessee College of Medicine (Nashville)Residency, Surgery, 1994 - 1996
University of Oklahoma College of MedicineClass of 1994
Certifications & Licensure
MO State Medical License 2010 - 2027
KS State Medical License 2002 - 2026
NY State Medical License 2000 - 2002
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013, 2015-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013, 2015-2017
Clinical Trials
- Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy Start of enrollment: 2004 Aug 01
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
- Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients.Andrew J Armstrong, Daniel P Petrylak, Neal D Shore, Russell Z Szmulewitz, Jeffrey Holzbeierlein
European Urology. 2026-02-02 - 3 citationsEnzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.Arun A Azad, Daniel P Petrylak, Taro Iguchi, Neal D Shore, Arnauld Villers
JAMA Network Open. 2025-05-01 - Higher resilience in radical cystectomy patients is associated with improved health related quality of life post-operatively.Lauren N Kennedy, Caleb S Miller, Danica N May, Evan Fruhauf, Hadley W Wyre
Bladder Cancer. 2025-04-13
Press Mentions
Spotlight: Dr. Susan Lee, MDMay 22nd, 2024- AUA/SUO Release an Amendment to the Advanced Prostate Cancer GuidelineMay 2nd, 2023
- Early Detection of Prostate Cancer Guideline ReleasedApril 25th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
